BNVI Insider Trading Activity and SEC Form 4 Filings
BNVI insider trading summary
No open-market insider purchases or sales of Bionovo Inc (BNVI) have been reported on SEC Form 4 in the past 12 months.
Latest BNVI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 24, 2011 | George Butler | Director | Buy | $6K (10,000 @ $0.60) |
| Mar 23, 2011 | Thomas C Chesterman | Insider | Buy | $6K (10,000 @ $0.61) |
| Nov 5, 2010 | George Butler | Director | Buy | $9K (10,000 @ $0.91) |
| Oct 19, 2010 | Louis Drapeau | Director | Buy | $10K (10,000 @ $0.97) |
| Jun 2, 2009 | Mary Tagliaferri | VP, Chief Regulatory Officer | Sell | $5K (10,000 @ $0.45) |
| Dec 1, 2008 | Louis Drapeau | Director | Buy | $6K (17,000 @ $0.38) |
| Nov 28, 2008 | Louis Drapeau | Director | Buy | $5K (13,000 @ $0.35) |
| Nov 20, 2007 | Michael D Vanderhoof | Director | Buy | $50K (25,000 @ $2.00) |
| Nov 19, 2007 | Isaac Cohen | Chairman, Chief Exe. Officer | Buy | $49K (27,000 @ $1.80) |
| Nov 9, 2007 | Brooks A Corbin | Director | Buy | $225K (100,000 @ $2.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.